A SINGLE CENTER RESTROSPECTIVE REVIEW OF RECURRENT OR TREATMENT REFRACTORY PEDIATRIC MEDULLOBLASTOMA

被引：0
|
作者：
Kameda-Smith, Michelle [1 ]
Manoranjan, Branavan [1 ]
Ajani, Olufemi [1 ]
Yarascavitch, Blake [1 ]
Petrelli, Tina [1 ]
Singh, Sheila [1 ]
Fleming, Adam [1 ]
机构：
[1] McMaster Univ, Hamilton, ON, Canada
来源：
NEURO-ONCOLOGY | 2017年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EPID-17
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol
    Adile, Ashley A.
    Kameda-Smith, Michelle M.
    Bakhshinyan, David
    Banfield, Laura
    Salim, Sabra K.
    Farrokhyar, Forough
    Fleming, Adam J.
    SYSTEMATIC REVIEWS, 2020, 9 (01)
  • [2] Salvage therapy for progressive, treatment-refractory or recurrent pediatric medulloblastoma: a systematic review protocol
    Ashley A. Adile
    Michelle M. Kameda-Smith
    David Bakhshinyan
    Laura Banfield
    Sabra K. Salim
    Forough Farrokhyar
    Adam J. Fleming
    Systematic Reviews, 9
  • [3] Bevacizumab and Irinotecan in the Treatment of Children With Recurrent/Refractory Medulloblastoma
    Aguilera, Dolly G.
    Goldman, Steward
    Fangusaro, Jason
    PEDIATRIC BLOOD & CANCER, 2011, 56 (03) : 491 - 494
  • [4] A Single Center Experience of a Treatment for Medulloblastoma
    Ince, D.
    Mutafoglu, K.
    Kizmazoglu, D.
    Kizmazoglu, C.
    Cetinayak, O.
    Erdem, M.
    Yenigurbuz, F.
    Ataseven, E.
    Guleryuz, H.
    Ozer, E.
    Kalemci, O.
    Demiral, A.
    Olgun, N.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S134 - S134
  • [5] NIVOLUMAB IN THE TREATMENT OF RECURRENT OR REFRACTORY PEDIATRIC BRAIN TUMORS: A SINGLE INSTITUTIONAL EXPERIENCE
    Gorsi, Hamza
    Malicki, Denise
    Khanna, Paritosh
    Elster, Jennifer
    Barsan, Valentin
    Tumblin, Mark
    Yeh-Nayre, Lanipua
    Milburn, Mehrzad
    Crawford, John
    NEURO-ONCOLOGY, 2018, 20 : 100 - 100
  • [6] Nivolumab in the Treatment of Recurrent or Refractory Pediatric Brain Tumors: A Single Institutional Experience
    Gorsi, Hamza S.
    Malicki, Denise M.
    Barsan, Valentin
    Tumblin, Mark
    Yeh-Nayre, Lanipua
    Milburn, Mehrzad
    Elster, Jennifer D.
    Crawford, John R.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2019, 41 (04) : E235 - E241
  • [7] Everolimus/sorafenib combination in the treatment of refractory pediatric osteosarcomas: Single center experience.
    Fedenko, Alexander A.
    Senzhapova, Elmira
    Aliev, Mamed
    Dzampaev, Asian
    Bokhyan, Beniamin
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [8] Ustekinumab for the treatment of refractory pediatric Crohn's disease: a single-center experience
    Cohen, Alexandra
    Ahmed, Najma
    Sant'Anna, Ana
    INTESTINAL RESEARCH, 2021, 19 (02) : 217 - 224
  • [9] TREATMENT STRATEGIES FOR RECURRENT MEDULLOBLASTOMA - REPORT OF A SINGLE INSTITUTION EXPERIENCE
    Gilheeney, S. W.
    McLaren, S.
    Dreyfus, H.
    Becher, O. J.
    Khakoo, Y.
    Kramer, K.
    Lyden, D. C.
    Souweidane, M.
    Wolden, S.
    Dunkel, I. J.
    NEURO-ONCOLOGY, 2010, 12 (06) : II62 - II62
  • [10] Oral procainamide as pharmacological treatment of recurrent and refractory ventricular tachyarrhythmias: A single-center experience
    Toniolo, Mauro
    Muser, Daniele
    Grilli, Giulia
    Burelli, Massimo
    Rebellato, Luca
    Daleffe, Elisabetta
    Facchin, Domenico
    Imazio, Massimo
    HEART RHYTHM O2, 2021, 2 (06): : 840 - 847
12345